Engineering Porous Particles of Water Soluble Therapeutics for Pressurized Metered-dose Inhaler Formulations

The subject matter disclosed herein relates to methods for engineering porous particles of water soluble therapeutics with enhanced physical stability and aerosol characteristics in hydrofluoroalkane (HFA)-based pressurized metered-dose inhaler (pMDI) formulations.

Attached files:
WO 2010057215.jpg

Patents:
WO 2,010,057,215

Inventor(s): DA ROCHA SANDRO RP [US]; WU LIBO [US]

Type of Offer: Licensing

Contact Patent Owner or Broker


« More Biotech Patents

Share on      

CrowdSell Your Patent